Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)

by Camerini, Andrea, Puccetti, Cheti, Donati, Sara, Valsuani, Chiara, Petrella, Maria Cristina, Tartarelli, Gianna, Puccinelli, Paolo, Amoroso, Domenico
Published in BMC Cancer (2015)

High anthracycline cumulative dose without cardiac toxicity: A possible protective role of morphine

by Canale, Maria Laura, Camerini, Andrea, Magnacca, Massimo, Meglio, Jacopo Del, Lilli, Alessio, Donati, Sara, Amoroso, Domenico, Casolo, Giancarlo
Published in Anatol J Cardiol (2018)

Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report

by Valsuani, Chiara, Siclari, Olimpia, Camerini, Andrea, Canale, Maria Laura, Rondini, Marianna, Donati, Sara, Puccinelli, Paolo, Tartarelli, Gianna, Puccetti, Cheti, Amoroso, Domenico
Published 2009

Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer

by Martini Leonardo, De Luca Filomena, Valsuani Chiara, Tartarelli Gianna, Puccetti Cheti, Siclari Olimpia, Viacava Paolo, Donati Sara, Camerini Andrea, Cavazzana Andrea, Amoroso Domenico
Published 2011-04-01

Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer

by Camerini, Andrea, Donati, Sara, Viacava, Paolo, Siclari, Olimpia, Puccetti, Cheti, Tartarelli, Gianna, Valsuani, Chiara, De Luca, Filomena, Martini, Leonardo, Cavazzana, Andrea, Amoroso, Domenico
Published 2011

Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy

by Canale, Maria Laura, Camerini, Andrea, Casolo, Giancarlo, Lilli, Alessio, Bisceglia, Irma, Parrini, Iris, Lestuzzi, Chiara, Del Meglio, Jacopo, Puccetti, Cheti, Camerini, Lara, Amoroso, Domenico, Maurea, Nicola
Published in Adv Ther (2020)

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study

by Clavarezza, Matteo, Mustacchi, Giorgio, Casadei Gardini, Andrea, Del Mastro, Lucia, De Matteis, Andrea, Riccardi, Ferdinando, Adamo, Vincenzo, Aitini, Enrico, Amoroso, Domenico, Marchetti, Paolo, Gori, Stefania, Carrozza, Francesco, Maiello, Evaristo, Giotta, Francesco, Dondi, Davide, Venturini, Marco
Published 2012

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

by Marmorino, Federica, Salvatore, Lisa, Barbara, Cecilia, Allegrini, Giacomo, Antonuzzo, Lorenzo, Masi, Gianluca, Loupakis, Fotios, Borelli, Beatrice, Chiara, Silvana, Banzi, Maria Chiara, Miraglio, Emanuela, Amoroso, Domenico, Dargenio, Francesco, Bonetti, Andrea, Martignetti, Angelo, Paris, Myriam, Tomcikova, Daniela, Boni, Luca, Falcone, Alfredo, Cremolini, Chiara
Published in Br J Cancer (2017)

Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA

by Del Re, Marzia, Tiseo, Marcello, Bordi, Paola, D'Incecco, Armida, Camerini, Andrea, Petrini, Iacopo, Lucchesi, Maurizio, Inno, Alessandro, Spada, Daniele, Vasile, Enrico, Citi, Valentina, Malpeli, Giorgio, Testa, Enrica, Gori, Stefania, Falcone, Alfredo, Amoroso, Domenico, Chella, Antonio, Cappuzzo, Federico, Ardizzoni, Andrea, Scarpa, Aldo, Danesi, Romano
Published in Oncotarget (2016)